This brand name is authorized in Cyprus, Malta
The drug ORFENAL contains one active pharmaceutical ingredient (API):
|
1
Orphenadrine
UNII UBY910DUXH - ORPHENADRINE HYDROCHLORIDE
|
|
Orphenadrine, which is a congener of diphenhydramine without sharing its soporific effect, is an anti-muscarinic agent. Orphenadrine is used as the hydrochloride in the symptomatic treatment of Parkinsonism. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N04AB02 | Orphenadrine (chloride) | N Nervous system → N04 Anti-parkinson drugs → N04A Anticholinergic agents → N04AB Ethers chemically close to antihistamines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: MT | Medicines Authority | Identifier(s): MA084/01601 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
